• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Congestive heart failure in dialysis patients.

作者信息

Parfrey P S, Harnett J D, Griffiths S M, Gault M H, Barré P E

机构信息

Division of Nephrology, Memorial University, St John's, Newfoundland, Canada.

出版信息

Arch Intern Med. 1988 Jul;148(7):1519-25.

PMID:3382298
Abstract

To determine the prevalence of congestive heart failure in dialysis patients and the disorders with which it is associated, 85% of 153 nondiabetic patients who were undergoing maintenance dialysis had echocardiography and gated cardiac scan. Ten percent (n = 15) had congestive heart failure, 53% (n = 8) of whom had dilated cardiomyopathy, and 47% (n = 7) had hypertrophic hyperkinetic cardiomyopathy. Ischemic heart disease was an additional independent risk factor for congestive heart failure. Significantly more of those patients with dilated cardiomyopathy were smokers and none were hypertensive, whereas all those patients with hypertrophic cardiomyopathy were hypertensive. The prevalence of hypertrophic hyperkinetic disease was 11%, of dilated cardiomyopathy 18%, and of symptomatic ischemic heart disease 18%. We concluded that congestive heart failure in dialysis patients is associated not only with dilated cardiomyopathy but also with hypertrophic cardiomyopathy, a disease that requires echocardiography for diagnosis and that has different risk factors and management.

摘要

相似文献

1
Congestive heart failure in dialysis patients.
Arch Intern Med. 1988 Jul;148(7):1519-25.
2
Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients.透析患者充血性心力衰竭、扩张型心肌病、肥厚性高动力性疾病及缺血性心脏病的预后。
Am J Nephrol. 1990;10(3):213-21. doi: 10.1159/000168084.
3
[Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].[伴有左心室扩张和充血性心力衰竭的肥厚型心肌病:与心肌炎后心脏扩大和高血压性心力衰竭的比较]
J Cardiogr. 1983 Sep;13(3):537-50.
4
[Clinical significance of serum carnitine in the course and prognosis of dilated cardiomyopathy].[血清肉碱在扩张型心肌病病程及预后中的临床意义]
Z Kardiol. 1987 Jan;76(1):15-24.
5
[Patterns in the development of chronic heart failure in different morphofunctional types of myocardial lesion].[不同形态功能类型心肌病变中慢性心力衰竭的发展模式]
Ter Arkh. 1987;59(5):37-41.
6
Predictors of death from congestive heart failure in hypertrophic cardiomyopathy.
Am J Cardiol. 1999 Apr 15;83(8):1280-3, A9.
7
["Severe" congestive heart failure at a medical center].[某医疗中心的“重度”充血性心力衰竭]
Rev Port Cardiol. 1993 Nov;12(11):919-30, 900.
8
[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].[植入式心脏复律除颤器的14年经验:预后和出院行为的判定]
Z Kardiol. 2000;89 Suppl 3:194-205.
9
Pathophysiology of congestive heart failure secondary to congestive and ischemic cardiomyopathy.充血性和缺血性心肌病继发的充血性心力衰竭的病理生理学
Cardiovasc Clin. 1988;19(1):57-74.
10
Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.特发性扩张型心肌病患者β-肾上腺素能受体基因多态性与心力衰竭进展的相关性
Am J Med. 2004 Oct 1;117(7):451-8. doi: 10.1016/j.amjmed.2004.04.012.

引用本文的文献

1
A comparison of fluid status determination using bioelectric impedance and the isotope dilution method in hemodialysis and peritoneal dialysis patients.生物电阻抗法与同位素稀释法在血液透析和腹膜透析患者液体状态评估中的比较。
Ren Fail. 2022 Dec;44(1):1698-1707. doi: 10.1080/0886022X.2022.2132960.
2
Effects of the Type of Intraoperative Fluid in Living Donor Kidney Transplantation: A Single-Center Retrospective Cohort Study.供体肾移植术中不同液体类型的影响:一项单中心回顾性队列研究。
Yonsei Med J. 2022 Apr;63(4):380-388. doi: 10.3349/ymj.2022.63.4.380.
3
Is N-terminal pro-brain natriuretic peptide a reliable marker for body fluid status in children with chronic kidney disease?
N端前脑钠肽是否是慢性肾病患儿体液状态的可靠标志物?
Arch Med Sci. 2019 Jun 3;16(4):802-810. doi: 10.5114/aoms.2019.85460. eCollection 2020.
4
Clinical usefulness of bioimpedance analysis for assessing volume status in patients receiving maintenance dialysis.生物电阻抗分析在评估维持性透析患者容量状态中的临床应用价值。
Korean J Intern Med. 2018 Jul;33(4):660-669. doi: 10.3904/kjim.2018.197. Epub 2018 Jun 28.
5
Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome.儿童心肾综合征的流行病学、病理生理学、临床特征及管理
World J Nephrol. 2012 Feb 6;1(1):16-24. doi: 10.5527/wjn.v1.i1.16.
6
Mechanisms of the cardiorenal syndromes.心肾综合征的发病机制。
Nat Rev Nephrol. 2009 Nov;5(11):641-9. doi: 10.1038/nrneph.2009.156. Epub 2009 Sep 29.
7
Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients.儿科透析患者的左心室质量和主动脉可扩张性异常。
Pediatr Nephrol. 2005 Jan;20(1):64-8. doi: 10.1007/s00467-004-1667-x. Epub 2004 Oct 27.
8
Drug therapy in haemodialysis patients. Special considerations in the elderly.血液透析患者的药物治疗。老年人的特殊注意事项。
Drugs Aging. 1998 Jun;12(6):441-59. doi: 10.2165/00002512-199812060-00003.
9
Improvement of left ventricular function after renal transplantation in a patient with uremic cardiomyopathy: report of a case.尿毒症性心肌病患者肾移植后左心室功能的改善:病例报告
Surg Today. 1993;23(11):998-1002. doi: 10.1007/BF00308977.